Skip to content

Randomized Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation

Randomized Controlled Trial of Transcranial Theta-burst Stimulation and Transcranial Direct Current Stimulation in Subacute Stroke

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02031107
Enrollment
41
Registered
2014-01-09
Start date
2013-09-30
Completion date
2016-03-31
Last updated
2016-05-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Keywords

stroke, brain stimulation, electroencephalography, functional magnetic resonance imaging, functional connectivity

Brief summary

Background: Stroke is a leading cause of adult disability. Non-invasive brain stimulation can induce significant and sustained improvements in functional outcome. However the effect is inconsistent and difficult to predict, in particular in the subacute phase after stroke. Although several different stimulation techniques are available, it is unknown which is suitable for which patient. Objectives: This study has three main objectives: 1. To compare the effects of two techniques of non-invasive brain stimulation (cTBC, continuous theta-burst stimulation; tDCS, direct current transcranial stimulation) on clinical recovery in patients with subacute stroke. 2. To assess the effect of these brain stimulation techniques on brain organization with non-invasive imaging. 3. To find clinical and neural predictors of responsiveness to brain stimulation therapy. Method: 45 patients with ischemic or hemorrhagic stroke will be randomly assigned to one of 3 groups: cTBS, tDCS, or sham stimulation. Each group will receive the corresponding stimulation therapy 3 times per week for 3 weeks, immediately before intensive physical therapy. Before and after the treatment period, standardized assessments of sensorimotor function areas are obtained together with electroencephalography and functional magnetic resonance recordings. These recordings will be used to analyze and compare the neural effects of each treatment modality. Clinical Implication: The results of this study might help optimize and individualize stimulation treatment for patients with subacute stroke. It may hence facilitate the transfer of brain stimulation therapy to routine clinical practice.

Interventions

DEVICEcTBS
DEVICEsham stimulation

Sponsors

Swiss National Science Foundation
CollaboratorOTHER
Adrian Guggisberg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
16 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* ischemic or hemorrhagic stroke leading to unilateral deficits in motor function with significant impact on independence and daily activities at the beginning of rehabilitation * less than 10 weeks after stroke onset.

Exclusion criteria

* epileptic seizures * metallic objects in the brain * presence of implants or neural stimulators * pregnancy * sleep deprivation * recent traumatic brain injury * delirium or disturbed vigilance * inability to participate in 1h treatment sessions * severe language comprehension deficits * skull breach * new stroke lesions during rehabilitation * medical complications

Design outcomes

Primary

MeasureTime frameDescription
Change in compound motor score slope at week 4week 4 after treatment startThe Fugl Meyer motor assessment (FMA), the Nine Hole Peg test (expressed as pegs per minute), and the Jamar dynamometer strength of the affected arm are normalized to the healthy arm and averaged to a compound motor score. This score is obtained twice before treatment (at weeks -1 and 0 relative to treatment start), and twice after treatment (at weeks 4 and 8). Primary outcome measure is the change in slope from week 0 to 4 as compared to the slope between week -1 and 0.
Change in alpha-band coherence between the affected motor cortex and the rest of the brainWeek 4Calculated from electroencephalography recordings

Secondary

MeasureTime frame
Change in alpha-band coherence between the unaffected motor cortex and the rest of the brainWeek 4
Change in Fugl Meyer Upper Extremity Motor Score at week 4Week 4
Number of adverse eventsWeek 4
Change in activity of daily life scale (motor activity log, MAL)Week 4
Change in Fugl Meyer Upper Extremity Motor Score at week 8Week 8

Other

MeasureTime frameDescription
Change in average velocity in the Nine Hole Peg test at week 8Week 8expressed in pegs/sec
Correlation between change in alpha band coherence and clinical improvementsWeek 4Alpha band coherence is calculated from electroencephalography (EEG) recordings
Change in Jamar Dynamometer strength at week 4Week 4
Change in correlations of spontaneous fMRI fluctuations within the motor networkWeek 4Calculated from functional magnetic resonance (fMRI) recordings
Change in fractional anisotropy of the affected cortico-spinal tractWeek 4Calculated from diffusion tensor imaging (DTI) sequences of magnetic
Change in Jamar Dynamometer strength at week 8Week 8
Change in Score of the Box and Block test, week 4Week 4
Change in Score of the Box and Block test, week 8week 8
Total Fugl Meyer motor assessment score at week 4Week 4
Total Fugl Meyer motor assessment score at week 8Week 8
Change in average velocity in the Nine Hole Peg test at week 4Week 4expressed in pegs/sec

Countries

Switzerland

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026